NovaBay Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

NovaBay Pharmaceuticals Inc share price today is $1.16, up -4.92%. The stock opened at $1.22 against the previous close of $1.22, with an intraday high of $1.25 and low of $1.16.

NovaBay Pharmaceuticals Inc Share Price Chart

NovaBay Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
us-stock

NovaBay Pharmaceuticals Inc Share Price Performance

$1.16 -0.0492(-4.92%) NBY at 23 Mar 2026 02:25 PM Biotechnology
Lowest Today 1.16
Highest Today 1.25
Today’s Open 1.22
Prev. Close 1.22
52 Week High 99.75
52 Week Low 1.11
Day’s Range: Low 1.16 High 1.25
52-Week Range: Low 1.11 High 99.75
1 day return -
1 Week return -20.27
1 month return -44.07
3 month return -78.3
6 month return -43.54
1 year return +93.91
3 year return -97.75
5 year return -99.9
10 year return -

NovaBay Pharmaceuticals Inc Institutional Holdings

NovaBay Pharmaceuticals Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

NovaBay Pharmaceuticals Inc Fundamentals

Market Cap 30.30 M

PB Ratio 1.5314

PE Ratio 0.045

Enterprise Value 32.76 M

Total Assets 9.04 M

Volume 132574

NovaBay Pharmaceuticals Inc Company Financials

Annual Revenue FY23:14642000 14.6M, FY22:14404000 14.4M, FY21:8421000 8.4M, FY20:9934000 9.9M, FY19:6599000 6.6M

Annual Profit FY23:7835000 7.8M, FY22:7781000 7.8M, FY21:5645000 5.6M, FY20:5964000 6.0M, FY19:4861000 4.9M

Annual Net worth FY23:-13738000 -13.7M, FY22:-16265000 -16.3M, FY21:-6559000 -6.6M, FY20:-11039000 -11.0M, FY19:-10487000 -10.5M

Quarterly Revenue Q3/2025:521000 0.5M, Q2/2025:0 0.0M, Q1/2025:2309000 2.3M, Q3/2024:2441000 2.4M, Q2/2024:2400000 2.4M

Quarterly Profit Q3/2025:42000 0.0M, Q2/2025:-38000 -0.0M, Q1/2025:1502000 1.5M, Q3/2024:1593000 1.6M, Q2/2024:1592000 1.6M

Quarterly Net worth Q3/2025:-1293000 -1.3M, Q2/2025:-1922000 -1.9M, Q1/2025:7670000 7.7M, Q3/2024:-1212000 -1.2M, Q2/2024:-1585000 -1.6M

About NovaBay Pharmaceuticals Inc & investment objective

Company Information NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Michael Kazley

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NovaBay Pharmaceuticals Inc FAQs

What is the share price of NovaBay Pharmaceuticals Inc today?

The current share price of NovaBay Pharmaceuticals Inc is $1.16.

Can I buy NovaBay Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy NovaBay Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy NovaBay Pharmaceuticals Inc shares in India?

You can easily invest in NovaBay Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of NovaBay Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NovaBay Pharmaceuticals Inc?

NovaBay Pharmaceuticals Inc has a market cap of $30.30 M.

In which sector does NovaBay Pharmaceuticals Inc belong?

NovaBay Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in NovaBay Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of NovaBay Pharmaceuticals Inc?

The PE ratio of NovaBay Pharmaceuticals Inc is 0.05 and the PB ratio is 1.53.